|
US6685940B2
(en)
|
1995-07-27 |
2004-02-03 |
Genentech, Inc. |
Protein formulation
|
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
|
US20040197326A1
(en)
*
|
1995-07-27 |
2004-10-07 |
Genentech, Inc. |
Method for treatment of allergic asthma
|
|
US20040146507A1
(en)
*
|
1996-11-27 |
2004-07-29 |
Genentech, Inc. |
Antibody mutants
|
|
US7122636B1
(en)
|
1997-02-21 |
2006-10-17 |
Genentech, Inc. |
Antibody fragment-polymer conjugates and uses of same
|
|
US6172213B1
(en)
*
|
1997-07-02 |
2001-01-09 |
Genentech, Inc. |
Anti-IgE antibodies and method of improving polypeptides
|
|
US5994511A
(en)
*
|
1997-07-02 |
1999-11-30 |
Genentech, Inc. |
Anti-IgE antibodies and methods of improving polypeptides
|
|
US7393529B2
(en)
*
|
1998-04-09 |
2008-07-01 |
Idexx Laboratories, Inc. |
Methods and compositions for inhibiting binding of IgE to a high affinity receptor
|
|
US6504013B1
(en)
|
2000-02-01 |
2003-01-07 |
Idexx Laboratories, Inc. |
Canine allergy therapeutic recombinant chimeric anti-IgE monoclonal antibody
|
|
US6818749B1
(en)
|
1998-10-31 |
2004-11-16 |
The United States Of America As Represented By The Department Of Health And Human Services |
Variants of humanized anti carcinoma monoclonal antibody cc49
|
|
US7759133B2
(en)
*
|
1998-12-22 |
2010-07-20 |
Alk-Abello A/S |
Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
|
|
GB9908533D0
(en)
|
1999-04-14 |
1999-06-09 |
Novartis Ag |
Organic compounds
|
|
US20020019009A1
(en)
*
|
1999-12-09 |
2002-02-14 |
Roggen Erwin Ludo |
High throughput screening (HTS) assays
|
|
KR100771294B1
(ko)
*
|
1999-12-14 |
2007-10-29 |
써모 바이오스타, 인크. |
폴리펩티드 및 항원 안정화 희석제
|
|
US7034121B2
(en)
*
|
2000-01-27 |
2006-04-25 |
Genetics Institue, Llc |
Antibodies against CTLA4
|
|
US7018801B2
(en)
*
|
2000-02-11 |
2006-03-28 |
Board Of Regents, The University Of Texas System |
Selection of peptides with antibody-like properties
|
|
EP1270596A4
(en)
*
|
2000-04-07 |
2003-06-04 |
Matsushita Electric Industrial Co Ltd |
ANTIBODY-CARRIER COMPLEX, METHOD OF ITS PRODUCTION, METHOD FOR CONTROLLING ANTIQUE-ANTIBODY REACTION BY USING THE COMPLEX AND IMMUNASSAY METHOD
|
|
US6951947B2
(en)
*
|
2000-07-13 |
2005-10-04 |
The Scripps Research Institute |
Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
|
|
US7176037B2
(en)
*
|
2000-07-13 |
2007-02-13 |
The Scripps Research Institute |
Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation
|
|
US8703126B2
(en)
|
2000-10-12 |
2014-04-22 |
Genentech, Inc. |
Reduced-viscosity concentrated protein formulations
|
|
DE60139944D1
(de)
*
|
2000-10-12 |
2009-10-29 |
Genentech Inc |
Niederviskose konzentrierte proteinformulierungen
|
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
|
US20030133939A1
(en)
|
2001-01-17 |
2003-07-17 |
Genecraft, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
WO2002072141A2
(en)
*
|
2001-03-09 |
2002-09-19 |
William Herman |
Targeted ligands
|
|
US6966992B2
(en)
*
|
2001-03-19 |
2005-11-22 |
Akzo Nobel Nv |
Method of purification of molecules using unbranched terminal alkyldiols
|
|
WO2002102303A2
(en)
*
|
2001-05-01 |
2002-12-27 |
Medimmune, Inc. |
Crystals and structure of synagis fab
|
|
CA2445269A1
(en)
*
|
2001-05-03 |
2002-11-14 |
Novartis Ag |
Anti-ige antibody to treat ocular allergies
|
|
GB0113179D0
(en)
|
2001-05-31 |
2001-07-25 |
Novartis Ag |
Organic compounds
|
|
EP1404813A4
(en)
*
|
2001-06-13 |
2004-11-24 |
Genentech Inc |
METHOD FOR CULTIVATING ANIMAL CELLS AND POLYPEPTIDE PRODUCTION IN ANIMAL CELLS
|
|
US20030073249A1
(en)
*
|
2001-07-07 |
2003-04-17 |
Lee Duen |
Allergen detection chip
|
|
JP2003137804A
(ja)
*
|
2001-10-31 |
2003-05-14 |
Morinaga Milk Ind Co Ltd |
インターロイキン−１８誘導剤
|
|
US7179798B2
(en)
*
|
2001-11-16 |
2007-02-20 |
Russell R. Roby |
Methods and compositions for the treatment of pain and other hormone-allergy-related symptoms using dilute hormone solutions
|
|
EP1464702A4
(en)
*
|
2001-12-28 |
2005-09-21 |
Chugai Pharmaceutical Co Ltd |
METHOD FOR PROTEIN STABILIZATION
|
|
AU2003207459A1
(en)
*
|
2002-01-03 |
2003-07-24 |
The Scripps Research Institute |
Cancer-associated epitope
|
|
GB0200429D0
(en)
*
|
2002-01-09 |
2002-02-27 |
Novartis Ag |
Organic compounds
|
|
US20050142539A1
(en)
*
|
2002-01-14 |
2005-06-30 |
William Herman |
Targeted ligands
|
|
DE60325334D1
(de)
*
|
2002-02-05 |
2009-01-29 |
Genentech Inc |
Proteinaufreinigung
|
|
US20040018573A1
(en)
*
|
2002-04-18 |
2004-01-29 |
Power Scott D |
Production of functional antibodies in filamentous fungi
|
|
CA2490659C
(en)
|
2002-06-28 |
2014-08-19 |
Syed V. S. Kashmiri |
Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
|
|
US20060034845A1
(en)
*
|
2002-11-08 |
2006-02-16 |
Karen Silence |
Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
|
|
ES2551682T3
(es)
*
|
2002-11-08 |
2015-11-23 |
Ablynx N.V. |
Anticuerpos de dominio simple dirigidos contra factor de necrosis tumoral-alfa y usos para los mismos
|
|
US20060034833A1
(en)
*
|
2002-11-08 |
2006-02-16 |
Els Beirnaert |
Single domain antibodies directed against interferron-gamma and uses therefor
|
|
US20100003253A1
(en)
*
|
2002-11-08 |
2010-01-07 |
Ablynx N.V. |
Single domain antibodies directed against epidermal growth factor receptor and uses therefor
|
|
JP2006520584A
(ja)
*
|
2002-11-08 |
2006-09-14 |
アブリンクス エン．ヴェー． |
安定化単一ドメイン抗体
|
|
US9320792B2
(en)
|
2002-11-08 |
2016-04-26 |
Ablynx N.V. |
Pulmonary administration of immunoglobulin single variable domains and constructs thereof
|
|
AU2003286004A1
(en)
*
|
2002-11-08 |
2004-06-07 |
Ablynx N.V. |
Single domain antibodies directed against interferon- gamma and uses therefor
|
|
US7056702B2
(en)
*
|
2002-12-16 |
2006-06-06 |
Kimberly Clark Co |
Detecting lipocalin
|
|
DK2000481T3
(en)
*
|
2003-02-01 |
2016-06-06 |
Tanox Inc |
High affinity anti-human IgE antibodies
|
|
US20060234296A1
(en)
*
|
2003-02-01 |
2006-10-19 |
Sanjaya Singh |
Method for generating high affinity antibodies
|
|
ATE486936T1
(de)
*
|
2003-03-05 |
2010-11-15 |
Chemo Sero Therapeut Res Inst |
Verfahren zur herstellung eines heterologen proteins in e. coli
|
|
PL1610820T5
(pl)
*
|
2003-04-04 |
2014-01-31 |
Genentech Inc |
Preparaty zawierające wysokoskoncentrowane przeciwciała i białka
|
|
US20050158303A1
(en)
*
|
2003-04-04 |
2005-07-21 |
Genentech, Inc. |
Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
|
|
GB2401040A
(en)
*
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
|
EP1621616A4
(en)
*
|
2003-04-30 |
2007-07-04 |
Japan Science & Tech Agency |
HUMAN ANTI-HUMAN INTERLEUKIN-18 ANTIBODY, FRAGMENT AND METHOD FOR THEIR USE
|
|
US20090263381A1
(en)
*
|
2003-07-31 |
2009-10-22 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026881A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050065136A1
(en)
*
|
2003-08-13 |
2005-03-24 |
Roby Russell R. |
Methods and compositions for the treatment of infertility using dilute hormone solutions
|
|
WO2005021594A2
(en)
*
|
2003-08-29 |
2005-03-10 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Minimally immunogenic variants of sdr-grafted humanized antibody cc49 and their use
|
|
BRPI0414154A
(pt)
*
|
2003-09-05 |
2006-10-31 |
Scripps Resarch Inst |
detecção de produtos de ozonização do colesterol
|
|
WO2005023830A2
(en)
*
|
2003-09-05 |
2005-03-17 |
The Scripps Research Institute |
Ozonation products of cholesterol for the treatment and prevention of atherosclerosis and/or cardiovascular diseases
|
|
CA2540165A1
(en)
*
|
2003-10-08 |
2005-04-21 |
Ebioscience |
Native immunoglobulin binding reagents and methods for making and using same
|
|
EP1688432B1
(en)
|
2003-10-09 |
2011-08-03 |
Chugai Seiyaku Kabushiki Kaisha |
Igm high concentration stabilized solution
|
|
EP1735453A2
(en)
*
|
2004-03-12 |
2006-12-27 |
The Scripps Research Institute |
Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities
|
|
EP3269738A1
(en)
|
2004-03-24 |
2018-01-17 |
Chugai Seiyaku Kabushiki Kaisha |
Subtypes of humanized antibody against interleukin-6 receptor
|
|
US20090111702A1
(en)
*
|
2004-04-06 |
2009-04-30 |
Mount Sinai School Of Medicine Office Of Industrial Liason |
Methods of determining allergen response using microarray immunoassay techniques
|
|
US20050239757A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Roby Russell R |
Hormone treatment of macular degeneration
|
|
GB0410627D0
(en)
*
|
2004-05-12 |
2004-06-16 |
Scancell Ltd |
Specific binding members
|
|
US7604947B2
(en)
*
|
2004-06-09 |
2009-10-20 |
Cornell Research Foundation, Inc. |
Detection and modulation of cancer stem cells
|
|
US8008447B2
(en)
|
2004-07-23 |
2011-08-30 |
Genentech, Inc. |
Crystallization of antibody or fragment thereof
|
|
US20060025390A1
(en)
*
|
2004-07-28 |
2006-02-02 |
Roby Russell R |
Treatment of hormone allergy and related symptoms and disorders
|
|
US7662926B2
(en)
|
2004-09-02 |
2010-02-16 |
Genentech, Inc. |
Anti-Fc-gamma receptor antibodies, bispecific variants and uses therefor
|
|
US7655229B2
(en)
|
2004-09-02 |
2010-02-02 |
Chan Andrew C |
Anti-FC-gamma RIIB receptor antibody and uses therefor
|
|
US20060051347A1
(en)
|
2004-09-09 |
2006-03-09 |
Winter Charles M |
Process for concentration of antibodies and therapeutic products thereof
|
|
US20090017016A1
(en)
*
|
2004-10-05 |
2009-01-15 |
Tanox Inc. |
Treatment and prevention of hypersensitivity and/or anaphylaxis with anti-ige antibodies in patients receiving replacement therapy
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
GT200600031A
(es)
*
|
2005-01-28 |
2006-08-29 |
|
Formulacion anticuerpo anti a beta
|
|
CN101111264A
(zh)
*
|
2005-01-28 |
2008-01-23 |
惠氏公司 |
稳定化的液体多肽制剂
|
|
GB0502358D0
(en)
*
|
2005-02-04 |
2005-03-16 |
Novartis Ag |
Organic compounds
|
|
JP5171611B2
(ja)
|
2005-03-25 |
2013-03-27 |
ナショナル リサーチ カウンシル オブ カナダ |
可溶性ポリペプチドの単離方法
|
|
EP1874821B1
(de)
|
2005-04-26 |
2013-04-17 |
Trion Pharma Gmbh |
Kombination von antikörpern mit glukokortikoiden zur behandlung von krebs
|
|
US8080249B2
(en)
*
|
2005-06-30 |
2011-12-20 |
Risk Glifford G |
Methods to treating chronic obstructive pulmonary disease
|
|
US10307481B2
(en)
|
2005-07-25 |
2019-06-04 |
Aptevo Research And Development Llc |
CD37 immunotherapeutics and uses thereof
|
|
WO2008020827A2
(en)
*
|
2005-08-01 |
2008-02-21 |
Biogen Idec Ma Inc. |
Altered polypeptides, immunoconjugates thereof, and methods related thereto
|
|
JP5389442B2
(ja)
*
|
2005-09-29 |
2014-01-15 |
メディミューン，エルエルシー |
膜Ｉｇ特異的抗体を同定する方法および免疫グロブリンを生成する前駆体細胞を標的化するための使用
|
|
JP2007172129A
(ja)
*
|
2005-12-20 |
2007-07-05 |
Sony Corp |
不揮発性メモリアクセス制御装置および不揮発性メモリ制御システム
|
|
CN101062949B
(zh)
*
|
2006-04-26 |
2011-07-27 |
上海抗体药物国家工程研究中心有限公司 |
重组抗人IgE单克隆抗体及其制备方法和用途
|
|
RU2487888C2
(ru)
|
2006-06-12 |
2013-07-20 |
ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ, ЭлЭлСи |
Одноцепочечные мультивалентные связывающие белки с эффекторной функцией
|
|
FR2902799B1
(fr)
|
2006-06-27 |
2012-10-26 |
Millipore Corp |
Procede et unite de preparation d'un echantillon pour l'analyse microbiologique d'un liquide
|
|
JP2010506839A
(ja)
*
|
2006-10-12 |
2010-03-04 |
ワイス エルエルシー |
乳光の低減を伴う方法および組成物
|
|
US8569464B2
(en)
|
2006-12-21 |
2013-10-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8362217B2
(en)
|
2006-12-21 |
2013-01-29 |
Emd Millipore Corporation |
Purification of proteins
|
|
US8163886B2
(en)
|
2006-12-21 |
2012-04-24 |
Emd Millipore Corporation |
Purification of proteins
|
|
AR065368A1
(es)
*
|
2007-02-15 |
2009-06-03 |
Astrazeneca Ab |
Anticuerpos para moleculas de ige
|
|
EP2592094A1
(en)
*
|
2007-02-15 |
2013-05-15 |
AstraZeneca AB |
Binding members for IgE molecules
|
|
RS53402B
(sr)
|
2007-03-22 |
2014-10-31 |
Genentech, Inc. |
Vezivanje apoptotskih anti-ige antitela za membranski ige
|
|
TW200904470A
(en)
*
|
2007-04-02 |
2009-02-01 |
Pfizer |
Anti-IgE antibodies
|
|
KR101626988B1
(ko)
*
|
2007-04-03 |
2016-06-02 |
암젠 리서치 (뮌헨) 게엠베하 |
종간 특이적 이중특이적인 결합제들
|
|
CN103694350B
(zh)
†
|
2007-04-03 |
2018-04-24 |
安进研发（慕尼黑）股份有限公司 |
跨物种特异性CD3-ε结合结构域
|
|
BRPI0810471A2
(pt)
*
|
2007-04-16 |
2014-11-11 |
Momenta Pharmaceuticals Inc |
Produtos de glicoproteína definidos e métodos relacionados
|
|
CL2008001334A1
(es)
*
|
2007-05-08 |
2008-09-22 |
Genentech Inc |
Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
|
|
SI4365189T1
(sl)
|
2007-07-09 |
2025-06-30 |
F. Hoffmann-La Roche Ag |
Preprečevanje redukcije disulfidne vezi med rekombinantno proizvodnjo polipeptidov
|
|
HRP20150282T4
(hr)
|
2007-10-30 |
2018-08-10 |
Genentech, Inc. |
Purifikacija protutijela pomoću kromatografije kationskom izmjenom
|
|
JP5373823B2
(ja)
*
|
2008-01-29 |
2013-12-18 |
アブリンクス エン．ヴェー． |
タンパク質及びポリペプチドを安定化する方法
|
|
US20220281964A1
(en)
*
|
2008-02-25 |
2022-09-08 |
Xencor, Inc. |
Fc VARIANTS WITH ALTERED BINDING TO FcRn
|
|
NZ603059A
(en)
|
2008-04-11 |
2014-07-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
US8999702B2
(en)
|
2008-06-11 |
2015-04-07 |
Emd Millipore Corporation |
Stirred tank bioreactor
|
|
IT1391559B1
(it)
*
|
2008-09-01 |
2012-01-11 |
Lofarma Spa |
Allergoidi derivati da allergeni
|
|
PT2853545T
(pt)
*
|
2008-09-17 |
2016-08-26 |
Xencor Inc |
Anticorpo específico para ige
|
|
CA2739352C
(en)
|
2008-10-29 |
2021-07-13 |
Wyeth Llc |
Methods for purification of single domain antigen binding molecules
|
|
US9393304B2
(en)
|
2008-10-29 |
2016-07-19 |
Ablynx N.V. |
Formulations of single domain antigen binding molecules
|
|
NZ620326A
(en)
*
|
2008-11-13 |
2015-07-31 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic combination therapies and uses thereof
|
|
WO2010068722A1
(en)
|
2008-12-12 |
2010-06-17 |
Medimmune, Llc |
Crystals and structure of a human igg fc variant with enhanced fcrn binding
|
|
CN105037535A
(zh)
|
2008-12-16 |
2015-11-11 |
Emd密理博公司 |
搅拌槽反应器及方法
|
|
SG174258A1
(en)
*
|
2009-03-06 |
2011-10-28 |
Genentech Inc |
Antibody formulation
|
|
WO2010137654A1
(ja)
|
2009-05-29 |
2010-12-02 |
株式会社未来創薬研究所 |
Egfファミリーリガンドのアンタゴニストを成分とする医薬組成物
|
|
RU2571929C2
(ru)
|
2009-09-01 |
2015-12-27 |
Дженентек, Инк. |
Улучшенная очистка белка посредством модифицированного элюирования белка а
|
|
MY182750A
(en)
|
2009-10-26 |
2021-02-05 |
Genentech Inc |
Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
|
|
PL2542257T3
(pl)
|
2010-03-01 |
2018-01-31 |
Bayer Healthcare Llc |
Zoptymalizowane przeciwciała monoklonalne przeciwko inhibitorowi szlaku czynnika tkankowego (TFPI)
|
|
KR20150002894A
(ko)
*
|
2010-03-11 |
2015-01-07 |
리나트 뉴로사이언스 코프. |
ｐＨ 의존성 항원 결합을 갖는 항체
|
|
PL2550018T3
(pl)
|
2010-03-22 |
2019-08-30 |
F.Hoffmann-La Roche Ag |
Kompozycje i sposoby użyteczne do stabilizowania preparatów zawierających białko
|
|
ES2993140T3
(en)
|
2010-04-02 |
2024-12-23 |
Amunix Pharmaceuticals Inc |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
EP2556163B1
(en)
|
2010-04-07 |
2016-08-10 |
Momenta Pharmaceuticals, Inc. |
Method for quantifying high mannose containing glycoforms
|
|
KR101551295B1
(ko)
|
2010-05-17 |
2015-09-08 |
이엠디 밀리포어 코포레이션 |
생체분자 정제용 자극 반응성 중합체
|
|
EP2600901B1
(en)
|
2010-08-06 |
2019-03-27 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
|
WO2012030512A1
(en)
|
2010-09-03 |
2012-03-08 |
Percivia Llc. |
Flow-through protein purification process
|
|
CN104531812A
(zh)
|
2010-10-01 |
2015-04-22 |
现代治疗公司 |
设计核酸及其使用方法
|
|
EP4029881A1
(en)
|
2010-11-08 |
2022-07-20 |
F. Hoffmann-La Roche AG |
Subcutaneously administered anti-il-6 receptor antibody
|
|
CN103782168B
(zh)
|
2011-03-12 |
2016-03-16 |
动量制药公司 |
在糖蛋白产品中包含n-乙酰己糖胺的n-聚醣
|
|
US8710200B2
(en)
|
2011-03-31 |
2014-04-29 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids encoding a modified erythropoietin and their expression
|
|
KR20140045440A
(ko)
|
2011-06-30 |
2014-04-16 |
제넨테크, 인크. |
항-c-met 항체 제제
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
BR112014007852B1
(pt)
|
2011-10-03 |
2021-11-03 |
Moderna Therapeutics, Inc |
Polinucleotídeo isolado modificado e composição farmacêutica
|
|
TWI679212B
(zh)
|
2011-11-15 |
2019-12-11 |
美商安進股份有限公司 |
針對ｂｃｍａ之e3以及ｃｄ３的結合分子
|
|
PL2791160T3
(pl)
|
2011-12-16 |
2022-06-20 |
Modernatx, Inc. |
Kompozycje zmodyfikowanego mrna
|
|
WO2013096791A1
(en)
|
2011-12-23 |
2013-06-27 |
Genentech, Inc. |
Process for making high concentration protein formulations
|
|
TWI593705B
(zh)
|
2011-12-28 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Humanized anti-epiregulin antibody and cancer therapeutic agent containing the antibody as an active ingredient
|
|
US20130243750A1
(en)
|
2012-01-31 |
2013-09-19 |
Genentech, Inc. |
Anti-ige antibodies and methods using same
|
|
WO2013120973A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Method of producing high-affinity antibodies
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
HK1206779A1
(en)
|
2012-04-02 |
2016-01-15 |
Modernatx, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
MX389346B
(es)
|
2012-05-18 |
2025-03-20 |
Genentech Inc |
Formulaciones de anticuerpos monoclonales de alta concentración.
|
|
WO2013181575A2
(en)
|
2012-06-01 |
2013-12-05 |
Momenta Pharmaceuticals, Inc. |
Methods related to denosumab
|
|
US20150140608A1
(en)
*
|
2012-06-01 |
2015-05-21 |
Momenta Pharmaceuticals, Inc. |
Methods related to omalizumab
|
|
FR2994390B1
(fr)
|
2012-08-10 |
2014-08-15 |
Adocia |
Procede d'abaissement de la viscosite de solutions de proteines a concentration elevee
|
|
US9592297B2
(en)
|
2012-08-31 |
2017-03-14 |
Bayer Healthcare Llc |
Antibody and protein formulations
|
|
US8613919B1
(en)
|
2012-08-31 |
2013-12-24 |
Bayer Healthcare, Llc |
High concentration antibody and protein formulations
|
|
EP2895197B1
(en)
*
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
|
DK2922554T3
(en)
|
2012-11-26 |
2022-05-23 |
Modernatx Inc |
Terminalt modificeret rna
|
|
US9738722B2
(en)
|
2013-01-15 |
2017-08-22 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US10450361B2
(en)
|
2013-03-15 |
2019-10-22 |
Momenta Pharmaceuticals, Inc. |
Methods related to CTLA4-Fc fusion proteins
|
|
EP2996772B1
(en)
|
2013-05-13 |
2018-12-19 |
Momenta Pharmaceuticals, Inc. |
Methods for the treatment of neurodegeneration
|
|
KR101815265B1
(ko)
|
2013-06-20 |
2018-01-04 |
한올바이오파마주식회사 |
FcRn 특이적 인간 항체 및 이를 포함하는 자가면역 질환 치료용 조성물
|
|
WO2015013668A1
(en)
*
|
2013-07-26 |
2015-01-29 |
Ke Zhang |
Anti-immunoglobulin e antibodies and methods of use thereof
|
|
CR20160132A
(es)
|
2013-08-12 |
2016-08-25 |
Genentech Inc |
Composiciones y método para tratar condiciones asociadas con el complemento
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
WO2015051214A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
EP3058084A4
(en)
|
2013-10-16 |
2017-07-05 |
Momenta Pharmaceuticals, Inc. |
Sialylated glycoproteins
|
|
KR20160090308A
(ko)
|
2013-11-04 |
2016-07-29 |
그렌마크 파머수티칼스 에스. 아. |
T 세포 재표적 이형-이량체 면역글로불린의 생산
|
|
JP6827636B2
(ja)
|
2013-11-13 |
2021-02-10 |
ジェネンテック， インコーポレイテッド |
補助装置付き手動注射装置と方法
|
|
MX2016014160A
(es)
*
|
2014-05-01 |
2017-02-16 |
Genentech Inc |
Variantes del anticuerpo anti-factor d y sus usos.
|
|
US10047166B2
(en)
*
|
2014-06-17 |
2018-08-14 |
Academia Sinica |
Humanized anti-IgE antibodies that crosslink CD23 on B lymphocytes but do not sensitize mast cells
|
|
ES2825574T3
(es)
|
2014-07-09 |
2021-05-17 |
Hoffmann La Roche |
Ajuste del pH para mejorar la recuperación por descongelación de bancos de células
|
|
WO2016014984A1
(en)
|
2014-07-24 |
2016-01-28 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
|
US11773166B2
(en)
|
2014-11-04 |
2023-10-03 |
Ichnos Sciences SA |
CD3/CD38 T cell retargeting hetero-dimeric immunoglobulins and methods of their production
|
|
WO2016164920A1
(en)
|
2015-04-09 |
2016-10-13 |
Cornell University |
Gene therapy to prevent reactions to allergens
|
|
UA126278C2
(uk)
|
2015-09-21 |
2022-09-14 |
Аптево Рісьорч Енд Девелопмент Ллс |
Поліпептиди, які зв'язують cd3
|
|
CN108472382A
(zh)
|
2015-10-30 |
2018-08-31 |
豪夫迈·罗氏有限公司 |
抗-因子d抗体变体缀合物及其用途
|
|
WO2017075173A2
(en)
|
2015-10-30 |
2017-05-04 |
Genentech, Inc. |
Anti-factor d antibodies and conjugates
|
|
GB201610198D0
(en)
*
|
2016-06-10 |
2016-07-27 |
Ucb Biopharma Sprl |
Anti-ige antibodies
|
|
ES3034904T3
(en)
|
2016-07-18 |
2025-08-27 |
Univ Ramot |
Modular platform for targeted therapeutics
|
|
WO2018089335A1
(en)
*
|
2016-11-09 |
2018-05-17 |
North Carolina State University |
Treatment of allergic diseases with chimeric protein
|
|
AU2017382281B2
(en)
|
2016-12-22 |
2024-07-11 |
Genentech, Inc. |
Methods and formulations for reducing reconstitution time of lyophilized polypeptides
|
|
CA3063324A1
(en)
|
2017-05-16 |
2018-11-22 |
Bhami's Research Laboratory, Pvt. Ltd. |
High concentration protein formulations with reduced viscosity
|
|
CN117820498A
(zh)
*
|
2017-08-10 |
2024-04-05 |
盖立复诊断解决方案公司 |
包含重组人类cd38细胞外结构域的组合物、方法和/或试剂盒
|
|
RU2758092C1
(ru)
*
|
2018-02-01 |
2021-10-26 |
Бэйцзин Кавин Текнолоджи Шеа-Холдинг Ко., Лтд. |
АНТИТЕЛО К IL-4Rα И ЕГО ПРИМЕНЕНИЕ
|
|
JP7418337B2
(ja)
|
2018-02-09 |
2024-01-19 |
ジェネンテック， インコーポレイテッド |
マスト細胞媒介性炎症性疾患の治療法及び診断法
|
|
WO2019183437A1
(en)
|
2018-03-23 |
2019-09-26 |
North Carolina State University |
Methods and compositions for antibody to high affinity receptor for ige
|
|
WO2021250546A1
(en)
|
2020-06-09 |
2021-12-16 |
University Of Washington |
Micrornas as predictors of response to anti-ige therapies in chronic spontaneous urticaria
|
|
TWI896700B
(zh)
*
|
2020-07-10 |
2025-09-11 |
大陸商上海濟煜醫藥科技有限公司 |
一種抗IgE的工程化抗體及其應用
|
|
CN111879923A
(zh)
*
|
2020-08-06 |
2020-11-03 |
深圳科隆生物新材料有限公司 |
一种可消除hama效应的试剂盒
|
|
US12467094B2
(en)
|
2021-03-11 |
2025-11-11 |
IgGenix, Inc. |
Methods and systems for predicting allergic response
|
|
EP4419912A4
(en)
*
|
2022-06-29 |
2025-10-29 |
Kashiv Biosciences Llc |
IMPROVED ANTIBODY ASSAY METHOD
|
|
US20250353930A1
(en)
*
|
2024-05-17 |
2025-11-20 |
Excellergy, Inc. |
Antibodies and antibody fragments that bind ige
|